Hagens berman, national trial attorneys, encourages acadia pharmaceuticals (acad) investors with losses to contact the firm to recover losses due to alleged securities fraud

San francisco, california--(newsfile corp. - may 17, 2021) - hagens berman urges acadia pharmaceuticals inc. (nasdaq: acad) investors with significant losses to submit your losses now.class period: june 15, 2020 - apr. 4, 2021lead plaintiff deadline: june 18, 2021visit: www.hbsslaw.com/investor-fraud/acadcontact an attorney now: acad@hbsslaw.com844-916-0895acadia pharmaceuticals inc. (nasdaq: acad) securities fraud action:the complaint alleges that defendants misrepresented facts concerning acadia's supplemental new drug application ("
ACAD Ratings Summary
ACAD Quant Ranking